How to Appeal "Experimental" Treatment Denials
One of the most difficult denials to receive is for a treatment your insurer has labeled as "experimental" or "investigational." This often happens with rare diseases, new technologies, or off-label use of approved drugs. While challenging, these denials can be overturned with the right evidence.
How Do Insurers Define "Experimental"?
Insurance companies have their own internal policies that define what they consider experimental. Generally, a treatment is deemed experimental if they believe there is not enough scientific evidence to prove it is safe and effective for your specific condition.
This definition can be problematic. A treatment may be widely accepted as the standard of care by medical experts in the field, but if it hasn't been through enough large-scale clinical trials to satisfy the insurer's criteria, they may still deny it. Your job in an appeal is to prove that the treatment is, in fact, established and beneficial.
Challenging the Denial with Evidence
Your appeal must be built on a foundation of strong scientific and medical evidence. You and your doctor need to demonstrate that the treatment is neither experimental nor investigational, but rather a medically appropriate option.
- Peer-Reviewed Literature: This is your most important tool. Work with your doctor to gather studies from reputable, peer-reviewed medical journals (like The New England Journal of Medicine, The Lancet, etc.) that show the treatment is safe and effective for patients in your situation.
- Clinical Practice Guidelines: See if major medical organizations (e.g., the American Cancer Society, American Heart Association) have issued guidelines that recommend the treatment.
- FDA Approval & Compendia: If appealing for a drug, check its FDA approval status. Even if it's for an "off-label" use, see if it is listed in official drug compendia (like the National Comprehensive Cancer Network Drugs & Biologics Compendium) for your condition, which insurers are often required to cover.
- Letter from Your Doctor: Your doctor's letter of medical necessity is crucial. It should not only explain why you need the treatment but also cite the supporting scientific literature.
The Power of External Review
Denials for experimental treatments have a particularly high success rate in the external review process. An independent reviewer who is a specialist in that specific medical field is more likely to be familiar with the latest research and standards of care than a general medical reviewer at an insurance company.
When an external reviewer examines your case, they will focus on the clinical evidence you and your doctor provide. They are not bound by the insurer's internal, and often outdated, definition of "experimental." This gives you a much better chance of getting an objective, evidence-based decision.